A Study of SHC014748M in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma
Clinical trial NCT04470141 · UNKNOWN
Trial details
- NCT number
- NCT04470141
- Sponsor
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2021-05-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.